Is Melanotan I legal or approved for tanning?

No. Injectable Melanotan I tanning products are unlicensed and not approved anywhere for cosmetic tanning. Regulators in several countries have warned consumers against buying or injecting them.

What is the difference between Melanotan I and Melanotan II?

They are different molecules. Melanotan I (afamelanotide) is more selective for MC1R and mainly affects pigmentation. Melanotan II acts more broadly across melanocortin receptors and is more associated with sexual side effects and priapism; it is also unapproved.

The injectable tanning form is not quality-controlled and its long-term safety is unknown. Because it darkens skin and can mask or alter moles, and because it bypasses medical monitoring, there are real concerns including melanoma reports linked to melanotan use.

Can Melanotan I give me a safe tan without sun?

It can increase pigmentation without UV in studies, but without sunburn does not mean safe. Using an unlicensed injectable to tan is unapproved, unmonitored, and carries skin-cancer and product-quality risks, so it is not a recommended tanning method.

Research chemical — not approved

Melanotan I — Complete Research Guide (2026)

Last updated 2026-06-30

TL;DR

Melanotan I is a peptide catalogued under Sexual Health. Neutral reference entry; EU status: not approved for human use (research use only).

What is Melanotan I?

Melanotan I is the older research name for [Nle4-D-Phe7]-alpha-MSH, chemically the same molecule now approved as afamelanotide (Scenesse) for erythropoietic protoporphyria.

As the term melanotan-i, it typically refers to the unregulated research/tanning framing of this compound, sold online as injectable powders for cosmetic tanning; in that form it is NOT an approved medicine and tanning use is unapproved and unsupervised.

Human data exist only from small early studies of skin pigmentation and pharmacokinetics; it should not be confused with Melanotan II, a different, more receptor-promiscuous and higher-risk peptide.

How does Melanotan I work?

Like afamelanotide, Melanotan I is an alpha-MSH analog that activates the melanocortin-1 receptor (MC1R) on melanocytes to stimulate eumelanin synthesis and skin darkening independent of UV.

It is more selective for MC1R than Melanotan II, which acts more broadly across melanocortin receptors (including MC4R) and is more associated with sexual and cardiovascular effects.

What does the research say about Melanotan I?

In early human studies, [Nle4-D-Phe7]-alpha-MSH increased skin eumelanin and produced measurable tanning even without added UV exposure. ^[2]
A controlled human study found the peptide combined with solar UV increased tanning of the skin in volunteers versus UV alone. ^[1]
Human pharmacokinetic work characterized dose-related skin pigmentation after subcutaneous melanotan-I administration. ^[3]

Clinical research & studies

The references below are the primary sources cited throughout this guide. Each links directly to PubMed or the regulator. Where evidence is preclinical (animal or in-vitro), that is stated rather than implied.

[1] Effects of a superpotent melanotropic peptide in combination with solar UV radiation on tanning of the skin in human volunteers — Dorr RT et al., Archives of Dermatology 2004. (Controlled human study)
[2] Increased eumelanin expression and tanning is induced by a superpotent melanotropin [Nle4-D-Phe7]-alpha-MSH in humans — Dorr RT et al., Photochemistry and Photobiology 2000. (Human study)
[3] Skin pigmentation and pharmacokinetics of melanotan-I in humans — Ugwu SO et al., Biopharmaceutics and Drug Disposition 1997. (Human pharmacokinetic study)
[4] Discovery and development of novel melanogenic drugs. Melanotan-I and -II — Hadley ME et al., Pharmaceutical Biotechnology 1998. (Narrative review)
[5] Use of melanotan I and II in the general population — Evans-Brown M et al., BMJ 2009. (Commentary / public-health report)
[6] Controlled-release delivery system for the alpha-MSH analog melanotan-I using poloxamer 407 — Bhardwaj R et al., Journal of Pharmaceutical Sciences 1996. (Preclinical formulation study)

Dosing context

This is not medical advice or a usage recommendation. Dosing figures are reported research context only, cited from the published literature.

There is no legitimate consumer dosing guidance for Melanotan I as a tanning agent, because tanning use is unapproved; the only regulated form of this molecule is the physician-administered afamelanotide implant for EPP.

This entry describes regulatory and safety context and does not provide instructions for obtaining or injecting any unlicensed product.

Side effects & safety profile

Products sold online as Melanotan I are unlicensed, not quality-controlled, and may be mislabeled or contaminated; regulators have warned against buying and injecting them, and long-term safety is not established.

Because MC1R agonists darken skin and can change the appearance of moles, and because these injectables bypass any medical monitoring, concerns include masked or new melanocytic lesions and reports of melanoma associated with melanotan use.

Melanotan II (a distinct compound often confused with it) has been linked in case reports to priapism, nausea, and cardiovascular effects; neither peptide in its injectable-tanning form is approved for cosmetic use.

Stacking & combinations

Combining Melanotan I with UV exposure, other melanocortin peptides, or Melanotan II is unstudied and increases uncertainty and risk rather than offering any validated benefit.

Finding Melanotan I vendors

This is an independent, neutral directory — we sell nothing and route no purchases. Use it to read regulatory context and (where available) genuine, moderated vendor information for your country.

Choose your country

We never list placeholder vendors. Pick your country to see neutral regulatory context.

Browse the directory

User reviews

No reviews yet

Reviews appear here once submitted and moderated. An aggregate rating is shown only after at least 5 genuine reviews — we never fabricate ratings.

Frequently asked questions

Yes, chemically. Both are [Nle4-D-Phe7]-alpha-MSH. Afamelanotide is the regulated, physician-administered implant approved for erythropoietic protoporphyria, while Melanotan I usually refers to the same molecule sold online, unregulated, for cosmetic tanning.

References

[1] Effects of a superpotent melanotropic peptide in combination with solar UV radiation on tanning of the skin in human volunteers — Dorr RT et al., Archives of Dermatology 2004. PMID: 15262693. View sourceStudy: Controlled human studyThe alpha-MSH analog plus solar UV increased skin tanning versus UV alone in volunteers.
[2] Increased eumelanin expression and tanning is induced by a superpotent melanotropin [Nle4-D-Phe7]-alpha-MSH in humans — Dorr RT et al., Photochemistry and Photobiology 2000. PMID: 11045725. View sourceStudy: Human studyThe peptide increased eumelanin and produced tanning in humans without required UV exposure.
[3] Skin pigmentation and pharmacokinetics of melanotan-I in humans — Ugwu SO et al., Biopharmaceutics and Drug Disposition 1997. PMID: 9113347. View sourceStudy: Human pharmacokinetic studyCharacterized dose-related skin pigmentation and pharmacokinetics after subcutaneous melanotan-I.
[4] Discovery and development of novel melanogenic drugs. Melanotan-I and -II — Hadley ME et al., Pharmaceutical Biotechnology 1998. PMID: 9760697. View sourceStudy: Narrative reviewReviews the discovery and development of Melanotan-I and Melanotan-II as melanogenic agents.
[5] Use of melanotan I and II in the general population — Evans-Brown M et al., BMJ 2009. PMID: 19224885. View sourceStudy: Commentary / public-health reportHighlights unregulated online sale and injection of melanotan I and II and associated safety concerns.
[6] Controlled-release delivery system for the alpha-MSH analog melanotan-I using poloxamer 407 — Bhardwaj R et al., Journal of Pharmaceutical Sciences 1996. PMID: 8877878. View sourceStudy: Preclinical formulation studyDeveloped a controlled-release delivery formulation for the melanotan-I peptide.

This article is for educational and research purposes only. Peptides discussed here are not approved for human consumption by the FDA, EMA, or equivalent regulators outside of specific clinical contexts. Always consult a licensed medical professional before any therapeutic use.